Risk for dying reduced for postmenopausal women receiving hormone replacement therapy, with increased estrogen levels
Metabolic Syndrome Ups Odds of ARDS, Death in COVID-19
For each additional metabolic syndrome criterion, risk for ARDS increases in an additive manner
2019 to 2020 Saw 16.8 Percent Increase in U.S. Death Rate
Age-specific death rates increased for each age group 15 years and older; COVID-19 became third leading cause of death in 2020
Severe Mental Illness Tied to Poorer COVID-19 Outcomes
Findings seen for COVID-19 infection, hospitalization, and mortality
U.S. COVID-19 Death Toll Passes 800,000
Rise from 700,000 to 800,000 happened in just 74 days compared with 119 days for the previous 100,000 increase in deaths
Rates of COVID-19, Severe Illness Lower With BNT162b2 Booster Dose
Second study shows reduction in rate of death due to COVID-19 with booster dose of BNT162b2
Most Immunosuppressive Meds Not Tied to Worse COVID-19 Outcomes
Except for rituximab, no increased risk seen for in-hospital death or mechanical ventilation for those on long-term immunosuppressive therapy
COVID-19 Positivity Lower for Some With Psychiatric Disorders
Patients with schizophrenia, mood disorders, anxiety disorders have increased odds of COVID-19 mortality
Risk for Stillbirth Elevated for Deliveries With COVID-19
Adjusted relative risk for stillbirth higher in deliveries with COVID-19 in pre-delta and delta periods, with stronger link during delta period
ICU Bed Occupancy During COVID-19 Linked to Increase in Excess Deaths
If ICU bed use reached 75 percent capacity nationwide, an excess of 12,000 deaths would be expected two weeks later